Vassal, G., Houghton, P. J., Pfister, S., Smith, M. A., Caron, H. N., Li, X., . . . Stancato, L. F. (2021). International consensus on minimum preclinical testing requirements for the development of innovative therapies for children and adolescents with cancer. Molecular cancer therapeutics, 20(8), . https://doi.org/10.1158/1535-7163.MCT-20-0394
Chicago-Zitierstil (17. Ausg.)Vassal, Gilles, et al. "International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies for Children and Adolescents with Cancer." Molecular Cancer Therapeutics 20, no. 8 (2021). https://doi.org/10.1158/1535-7163.MCT-20-0394.
MLA-Zitierstil (9. Ausg.)Vassal, Gilles, et al. "International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies for Children and Adolescents with Cancer." Molecular Cancer Therapeutics, vol. 20, no. 8, 2021, https://doi.org/10.1158/1535-7163.MCT-20-0394.